Drug Trial Radar · NCT00769314
Phase 3 Clinical Study for the Treatment of Cold Sore
Last checked: Nov 19, 2026Latest source record: Dec 21, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,727
Actual
Start
May 2007
Primary completion
Nov 2008
Study completion Aug 2009
Sponsor
- Lead sponsor
- Valerio TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Oct 9, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To demonstrate the efficacy of a single dose of acyclovir Lauriad® 50mg muco-adhesive buccal tablet versus a single dose of matching placebo on the primary vesicular lesion of cold sore.
Conditions
- Herpes Labialis
Interventions
Acyclovir LauriadDrug
50 mg muco-adhesive buccal tablets, single application on the gum
PlaceboDrug
50 mg muco-adhesive buccal tablets, single application on the gum
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Healing (TTH) of Vesicular Primary LesionTime frame: Assessed from time of treatment initiation through Day 14
Locations
53 sites in 7 countries. Site status is shown where the registry gives one.
Radiant Research, Inc.,
Scottsdale, Arizona
Radiant Research, Inc.,
Tucson, Arizona
Dermatology Private Practice
San Francisco, California
Front Range Clinical Research
Wheat Ridge, Colorado
St. Luke's Family Health,
Meridian, Idaho
Clinvest, a Division of Banyan Group, Inc.,
Springfield, Missouri
Rochester Clinical Research, Inc.,
Rochester, New York
Stony Brook University Medical Center
Stony Brook, New York
Center for Clinical Studies
Houston, Texas
Center for Clinical Studies, Ltd., LLP.
Houston, Texas
Taylor Square Private Clinic
Sydney, Australia
Central Brunswick Medical Centre
Sydney, Australia
General Teaching Hospital, Dep. Of Dermatology
Opava, Czechia
U zastavky 16
Opava, Czechia
Central military hospital Dept. of Dermatology
Prague, Czechia
University Hospital Bulovka 3rd Clinic of Inf. Diseases
Prague, Czechia
University Hospital Bulovka Dept. of Dermatology
Prague, Czechia
Hôpital St Jacques Service de Dermatologie
Besançon, France
Private Practice
Martigues, France
Hopital Fournier, Service de dermatologie
Nancy, France
Private Practice
Nice, France
Hôpital L'Archet 2, Service de Dermatologie
Nice, France
Private Practice
Paris, France
Hôpital Tenon, Dermatology department
Paris, France
Hôpital Saint Louis Paris, Service de Dermatologie 1
Paris, France
Service de Stomatologie et chirurgie Maxilo-Faciale.Hôpital de la pitié Salpétrière
Paris, France
Hôpital Nord, Service de dermatologie
Saint-Etienne, France
Hôpital TROUSSEAU
Tours, France
Praxis Dres. Dörzapf und Partner
Augsburg, Germany
Charité Universitätsmedizin Berlin Klinik für Dermatologie, Venerologie und Allergologie
Berlin, Germany
Praxis
Berlin, Germany
Polikum Friedenau
Berlin, Germany
Gemeinschaftspraxis
Berlin, Germany
Laserclinic Drs. Steinert
Biberach, Germany
Klinik und Poliklinik für Dermatologie des Universitätsklinikums Bonn
Bonn, Germany
Praxis
Frankfurt, Germany
Raiffeisenstr. 15b
Oberkirch, Germany
Ludwig-Erhard-Platz 9-11
Rodgau-Dudenhofen, Germany
Katedra i Klinika Dermatologii Collegium Medicum
Bydgoszcz, Poland
Centrum Medyczne Diabet
Chrzanów, Poland
Showing 40 of 53 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.